Skip to content

Rachel Grisham, M.D.

NPI 1528195971ActiveIndividual· Internal Medicine, Medical Oncology· New York, NY

Internal Medicine, Medical Oncology (M.D.) in New York, New York, trained at Duke University School of Medicine (class of 2006). Their prescriptions cost Medicare Part D more than their services did: $703,128 for 872 claims, against $60,570 paid for services in 2024. Merck Sharp & Dohme LLC was the largest of 3 companies reporting payments in 2025, $8,478 in all, mostly consulting fees.

Overview

NPI1528195971
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedFeb 27, 2007
Last updated in NPPESApr 5, 2012

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Medical Oncology Primary207RX0202X252458NY
Internal Medicine207R00000XL-228163MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Medical Oncology (NY)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients161
Services billed836 across 9 procedure codes
Paid by Medicare$60,570

Part D prescriptions in 2024

Prescriptions (claims)872 · 1,084 30-day fills
Patients140
Total drug cost$703,128
Generic share86% of claims

Medicare sources and data years

Education and affiliations

Medical schoolDuke University School of Medicine
Graduation year2006
Medicare specialtyMedical Oncology
Secondary specialtiesInternal Medicine
TelehealthOffers telehealth

Medical groups

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$8,478 · 4 payments from 3 companies
  • 2024$10,480 · 7 payments from 4 companies

Top paying companies in 2025

CompanyAmountPayments
Merck Sharp & Dohme LLC$4,4801
Incyte Corporation$2,3981
Genmab U.S., Inc.$1,6002

What the 2025 payments were for

  • Consulting Fee$8,478 · 4 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Medical Oncology providers in New York

All Internal Medicine, Medical Oncology providers in New York →